What is it about?
The virus that causes COVID-19 can change as it multiplies inside an infected person. We developed a tool called Beth-2 to look for genetic changes that are common within some patients but still rare in the wider population. Looking back at past outbreaks, we focused on the part of the virus’s spike protein that attaches to human cells. Beth-2 flagged nearly all the changes in that part of the spike that later became dominant in at least one of the regions we studied. The median lead time was about nine months.
Featured Image
Photo by Viktor Forgacs on Unsplash
Why is it important?
Spotting changes early gives researchers more time to find out which ones matter. We tested 26 mutations that Beth-2 flagged while they were still rare. In lab tests, 18 helped the spike protein attach more strongly to a receptor on human cells, and five made it harder for antibodies from vaccinated people to block that attachment. An early shortlist like this could help public health teams decide what to track and vaccine researchers decide what to test first.
Perspectives
What interests me most is how much we can learn by looking at the different versions of the virus in a single patient’s sample. When we summarize that sample as one genome, we lose some of that detail. I’d like to know whether looking more closely at patient samples could give us a similar head start with other fast-changing viruses.
shimin su
Chinese University of Hong Kong
Read the Original
This page is a summary of: Predicting key viral mutations from within-host deep sequencing data, Proceedings of the National Academy of Sciences, November 2026, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2536820123.
You can read the full text:
Contributors
The following have contributed to this page







